Jazz Pharmaceuticals plc looks very undervalued at 2.4x sales as oncology catalysts (Ziihera, Zepzelca, Epidiolex) drive ...
Franklin Resources' aggressive focus on Alternative Assets has failed to deliver management fee margin expansion, raising ...
RESEARCH TRIANGLE PARK, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Syncfusion®, Inc., the enterprise technology partner of choice, today announced Essential Studio® 2025 Volume 4. The release includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback